Xeljanz® ,


Ulcerative colitis ,
Drug Class
Targeted Synthetic Small Molecules
Delivery Method
Oral or
Brand name:
Xeljanz® ,
Drug name:
Drug type
JAK Inhibitor
Recommendations for pregnancy

Risks associated to mother and fetus in pregnancy. Pregnancy planning should be considered in women of reproductive age.

Recommendations for breastfeeding

No information on presence of this medication within human breast milk. Tofacitinib was found present in milk of lactating animal models. Breastfeeding while taking this medication is not advised.

Most common side effects

Common side effects may include infections in nose or sinus, headache, nausea, diarrhea, rash, throat irritation, high cholesterol, gastroenteritis, anemia, upper respiratory infection. Risks of lymphoma and other cancers are rare.


Patients should be tested for tuberculosis prior to starting tofacitinib. Avoid taking live vaccines while taking tofacitinib.

Learn more about Targeted Synthetic Small Molecules

YouTube Video (diZ-9aBqgwc)

Video Length 00:01:11

YouTube Video (diZ-9aBqgwc)